The FTC, Reverse Payments In The Obama Era
An impasse is looming in the pharmaceutical industry, and it is poised to provide insight into the approach that the Obama administration takes to antitrust regulation and enforcement....To view the full article, register now.
Already a subscriber? Click here to view full article